Use of toll-like receptor-9 agonists
US8518903B2 · kind B2 · utility
9Cited by
9References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 13, 2011 |
| Grant date | Aug 27, 2013 |
| Priority date | — |
| Expiry date | Sep 15, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2896
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.